Newsroom

About

Noble is an Aptar Pharma company focused on fostering healthy patient outcomes for those who self-administer drug therapies, through the development of robust training devices and onboarding solutions for the world’s top pharma brands and biotech companies. Noble manufactures and commercializes training devices that mimic the exact feel, force and function of drug delivery devices such as autoinjectors, prefilled syringes, onbody, nasal and pulmonary devices in order to increase patien...

Noble is an Aptar Pharma company focused on fostering healthy patient outcomes for those who self-administer drug therapies, through the development of robust training devices and onboarding solutions for the world’s top pharma brands and biotech companies. Noble manufactures and commercializes training devices that mimic the exact feel, force and function of drug delivery devices such as autoinjectors, prefilled syringes, onbody, nasal and pulmonary devices in order to increase patient adherence and confidence and decrease usage errors. Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, and food and beverage markets.

Press Contacts

Carolyn Reis, APR
Media relations contact
4075900251

Media Gallery

Resources (Files)

Standard of Care Infographic

Bios

Joe Reynolds is Sr. Manager, Strategy & Patient Insights at Noble, an Aptar Pharma company, where he develops and implements strategies to improve the patient experience and maximize value for stakeholders. He holds a Master of Science in Pharmacy and a Master Certificate in Drug Regulatory Affairs from the University of Florida, as well as a Bachelor of Science in Business Administration from the University of Central Florida and a Master of Science in Marketing from the University of South Florida.
https://cdn.filestackcontent.com/CHTdvOTJQXmoHJHuykAZ
Joe Reynolds
Sr. Manager, Strategy & Patient Insights
View more >>

Social Accounts